Position in PLRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$42
-$12,870 QoQ
Shares Held
34
-99.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Derivatives in PLRX
reported options exposure · as of Sep 30, 2024CallValue
$336,300
CallShares
30,000
PutValue
$336,300
PutShares
30,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. PLRX ranks #358 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in PLRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42 | 34 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,912 | 10,584 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $546,941 | 369,556 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $14,947 | 12,886 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $97,081 | 71,912 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $1,341,008 | 101,823 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $336,300 | 30,000 | Call | Sole | 2026-03-31 | |
| 2024-09-30 | $4,725,003 | 421,499 | Shares | Sole | 2026-03-31 | |
| 2024-09-30 | $336,300 | 30,000 | Put | Sole | 2026-03-31 | |
| 2024-06-30 | $645,000 | 60,000 | Call | Sole | 2026-03-23 | |
| 2024-06-30 | $3,686,433 | 342,924 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $5,366,160 | 360,145 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $6,390,964 | 352,897 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $4,235,571 | 244,266 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $1,668,417 | 92,076 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $313,374 | 11,781 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $512,534 | 26,515 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $116,899 | 5,596 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $92,988 | 11,609 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $108,535 | 15,483 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||